 |
 |
.jpg)
Expert Opinion on EmergingDrugs (ISSN 1472-8214 [print],1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, internationaljournal publishing structured reviews on Phase II and Phase III drugs/drugclasses emerging onto the market across all therapy areas, providing expert opinionon their potential impact on the current management of specific diseases.
Eachreview article is structured to include:
Concisebackground to the subject matter
Assessment ofmedical need for alternative or novel therapies
Assessment ofthe market and anticipated changes over time
Summary ofcurrent research goals
Outline of thescientific rationale for the approach(es) considered<
Analysis ofthe competitive environment
Discussion ofpotential development issues
<!--[if !supportLists]-->· <!--[endif]-->The author’sexpert opinion on the potential impact emerging therapies will have on thecurrent management of specific diseases
